Use of human CD147
A CD147, 1. CD147 technology, applied in the field of human CD147 use, can solve problems such as unclear underlying causes
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0051] In the embodiment of the present invention, the sperm of patients with normal fertility and asthenospermia were respectively used to detect the impact of CD147 deficiency on the normal function of sperm. The CD147 protein in human sperm was localized and quantified by immunofluorescent staining and Western blotting, and the expression and distribution of CD147 protein in sperm from the normal group and the asthenozoospermia group were compared. Correlation analysis of sperm motility.
[0052] 1. Materials and methods
[0053] 1) Reagent
[0054] Normal mouse IgG (Sc-2025) and mouse anti-human CD147 (Sc-20797) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA), USA, and discontinuous density gradient sperm separation liquid was purchased from Origio Company (SupraSperm#10970060, Origio Inc.).
[0055] 2) Collection and processing of human sperm samples
[0056] The embodiment of the present invention was approved by the Ethics Committee of the First Affili...
Embodiment 2
[0068] The embodiment of the present invention adopts antibody interference experiment to simulate the expression defect of sperm CD147 protein in vivo, and detect the influence of CD147 protein on sperm motility. At the same time, recombinant human CD147 protein was used to detect whether it had a remedial effect on sperm motility in the asthenozoospermia group.
[0069] The assessment of sperm quality involves other physiological functions besides sperm motility, including sperm capacitation, hyperactivation, acrosome reaction, and sperm-egg binding ability. In the embodiment of the present invention, rCD147 protein was also used to treat the sperm in the sperm of the asthenozoospermia group, and its promoting effect on the function of the sperm of the asthenozoospermia group was examined.
[0070] 1. Materials and methods
[0071] 1) Reagent
[0072] Discontinuous density gradient sperm separation medium (SupraSperm#10970060, Origio Inc.), Quinn's Advantage Fertilization ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com